IDEXX Laboratories is rated Hold, as its premium valuation already assumes strong recurring revenue and diagnostics growth.

Shares of IDEXX Laboratories Inc. IDXX shed 2.56% to $555.67 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.28% to 7,482.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Investors looking for stocks in the Medical - Instruments sector might want to consider either Alcon (ALC) or Idexx Laboratories (IDXX). But which of these two companies is the best option for those ...

IDEXX Laboratories, Inc.’s IDXX consistent strong performance of the CAG (Companion Animal Group) segment is poised to help it grow in the upcoming quarters. Robust demand for its cloud-based ...

Detailed price information for Veeva Systems Inc (VEEV-N) from The Globe and Mail including charting and trades.

With a short percentage of shares outstanding of 2.76%, IDEXX Laboratories, Inc. (NASDAQ:IDXX) is among the 7 Best Pet Care Stocks to Buy for Consistent Recurring Revenue. On May 26, IDEXX ...

One company that fits this best-of-both-worlds billing is Idexx Laboratories (IDXX +1.58%), offering leading pet healthcare diagnostics operations. Delivering annualized revenue and free-cash-flow ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 second quarter financial results for Tuesday, August 4, 2026, before the ...